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1. Introduction 
Cancers of the oral cavity and oropharynx account for approximatelly 3% of all 
malignancies among men and 2% among women in the United States, and oral squamous 
cell carcinoma represents 90% of these tumors. Despite great achievements concerning 
surgery, radiation and chemotherapy, survival rates in 5 years remain near 50 to 55%. As 
this survival time is directly related to the time of diagnosis of the lesion, prevention and 
early diagnosis remain important aspects to reduce incidence of the disease, as well as to 
enhance the survival rate of patients [1,2]. 
Oral squamous cell carcinoma can be preceded by potentially malignant alterations [1,3]. 
Such alterations are classified as potentially malignant due to the following evidence: 1) it 
was observed that these lesions evolved to malignant ones during follow-up; 2) typical 
alterations of potentially malignant lesions are seen co-existing in the margins of squamous 
cell carcinoma; 3) a proportion of these lesions show cytological and morphological 
alterations that are observed in malignant lesions; 4) some chromosomal, genomic, and 
molecular alterations are found in both, potentially malignant and malignant lesions [4].  
1.1. Definition, epidemiology, and etiology of oral leukoplakias 
In a recently published paper, leukoplakia has been defined as ‘‘a white plaque of 
questionable risk having excluded (other) known diseases or disorders that carry no 
increased risk for cancer” [5]. Nevertheless, the most used definition of leukoplakia is still 
the one proposed by the World Health Organization (WHO) in 1978, which states that 
“leukoplakia is a predominantly white patch that cannot be characterized clinically or 
histopathologically as any other definable lesion” [6,7].  
Oral leukoplakia (OL) is the most common potentially malignant lesion of the oral mucosa 
[1,3]. In a published systematic review [8], the author estimated a global prevalence of OL of 
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2.6%, which is in accordance with the consensus that OL prevalence is between 1% and 5% 
[9,10]. However, isolated reports show variable rates from 0.5% to 26.92% [8].  
OL is more frequent in middle-aged and elderly men, with higher indexes correlated with 
increased age. The most common sites are cheek, alveolar mucosa, and lower lip [1]. 
Nonetheless, lesions affecting the floor of the mouth, lateral border of tongue, and lower lip 
seem to present displastic or malignant alterations more frequently [1,9]. 
The main risk factor associated with OL is the use of tobacco. OL is six times more frquent 
among smokers than non-smokers [10]. The effects of alcohol, betel, human papiloma virus, 
and diet are associated as well, but their exact role is yet to be established [1,9-11]. In addition, 
there are some OL for which no obvious aetiological factor can be identified, and these lesions 
are named idiopathic leukoplakias. It is believed that such lesions are significantly more prone 
to develop into cancer than those OL with known causative factors [9]. 
1.2. Clinical and histological features 
Clinically, OL can be classified as homogeneous and non-homogeneous lesions. 
Homogeneous OL arises as a white patch slightly elevated, thin, white to gray, uniform, and 
can present well defined borders or may gradually mix with normal adjacent mucosa 
(Figure 1 to 3). Non-homogeneous OL can be nodular, verrucous, or speckled 
(erythroplastic) (Figure 4) [4,10].  
 
Figure 1. Homogeneous thin leukoplakia in the tongue. 
 
Figure 2. Homogeneous leukoplakia in the lower lip. 
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Figure 3. Homogeneous thick leukoplakia in the tongue. 
 
Figure 4. Non-homogeneous (speckled) leukoplakia in the upper alveolar ridge. 
There is also the proliferative verrucous leukoplakia, characterized by multifocal 
evolvement, mainly in elderly female patients that do not present known risk factors (Figure 
5 and 6). These lesions are usually resistant to treatment and show a high risk for malignant 
transformation [4,10]. 
 
Figure 5. Proliferative verrucous leukoplakia. Notice the multifocal involvement in the lower gingiva. 
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Figure 6. Proliferative verrucous leukoplakia. This elderly woman presented multiple lesions affecting 
different sites of the oral mucosa. 
Many lesions must be excluded before formulating a diagnostic hypothesis of OL, such as 
chemical injuries, candidiasis, frictional lesion, hairy leukoplakia, leukoedema, linea alba, 
nicotinic stomatitis, among others [4,10]. Because of variable clinical presentation of the 
potentially malignant lesions, when a provisional clinical diagnosis of OL is made, a biopsy 
must be performed to obtain the histopathological diagnosis [12]. 
The microscopic presentation of OL can vary from slightly hyperkeratotic epithelium to 
lesions with severe dysplasia [13]. The frequencies of dysplastic or malignant alterations in 
OL vary from 15.6% to 39.2%, and a rate of 19.9% was found in a retrospective study of 3,300 
white lesions of the oral cavity [14]. Epithelial dysplasia is characterized by the presence of 
architectural alteration and cytological atypia, and can be graded as mild, moderate, severe, 
and carcinoma in situ [10]. Nevertheless, there is a notable inter- and intra-observer variation 
in the interpretation and classification of dysplasia, which makes this method subjective 
with low reproducibility [12,15]. Thus, many different grading systems have been suggested 
to enhance the reproducibility and the predictive value for malignant transformation of OL. 
It has been suggested a possible correlation between clinical and histopathological features 
of OL [16]. Following this proposal, thin and flat OL would show hyperkeratosis, 
acanthosis, and occasional lymphocytes. Thick fissured OL lesions would present, besides 
these microscopic alterations, mild to moderate dysplasia. The verrucous or granular OL 
would show irregular hyperkeratosis, drop-shaped rete ridges, a moderate amount of 
lymphocytes, and moderate to severe dysplasia. Finally, speckled OL and erythroplakia 
could show irregular hyperkeratosis, epithelial atrophy, numerous lymphocytes, and severe 
dysplasia or carcinoma in situ.  
A research group published a proposal of a staging system for OL, in which a clinical 
feature of the lesion would be taken into account [17,18]. The lesion would be classified into 
one of the four stages (I, II, III, or IV), according to the association between two parameters. 
The first characteristic to be evaluated would be the size of the lesion, with four possible 
categories (L1, L2, L3, and Lx). The second item concerned the histopathological presentation, 
focused on the presence of dysplasia, with three possible categories (P0, P1, and Px). 
Therefore, a somehow similar strategy to that of TNM (extent of the tumor (T), spread to 
regional lymph nodes (N), and distant metastasis (M)) for oral cancer would be used to 
stage OL, and the authors intended to promote a uniform reporting of treatment or 
management of OL lesions. 
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1.3. Evolution and prognosis 
OL may persist unchanged, progress, regress, or even disappear [9]. The malignant 
transformation risk varies from 3.6% to 36.0%, and some features such as the presence and 
degree of dysplasia, female gender, time of duration, non-smoker patient, location at floor of 
the mouth or tongue, size higher than 200mm², and non-homogeneous type, seem to be 
associated with a worse prognosis [10,19-22]. Surgical excision, cryosurgery, laser surgery, 
topical or systemic retinoids, therapy with mouth rinses with attenuated adenovirus, and 
photodynamic therapy are possible therapeutics [10,13,23]. Recurrence rates are highly 
variable among studies, from 0 to 30.0% [10]. 
Many efforts have attemped to identify molecular markers to predict cancer development in 
OL. However, the presence and degree of epithelial dysplasia in OL is yet regarded as the 
most relevant indicator of progression and prognosis, influencing the management of the 
patients [9,10,12].  
2. Grading oral epithelial dysplasia 
The term “dysplasia” is generally employed in the sense of a disordered development [24]. 
In a stratified squamous epithelium, architectural disturbances affecting normal maturation 
and stratification may occur. When such alterations are accompanied by cytological atypia, 
which can be detected as variations in the size and shape of the keratinocytes, the term 
“dysplasia” is applied [7,12].  
Despite many efforts towards new evaluative methods, the histological analysis is still the 
most useful method for grading epithelial dysplasia in OL [12].  
2.1. Relevance 
The concept of a sequential developmental process from a normal epithelium through a 
dysplasia, ending in a carcinoma, was introduced from studying pathological changes in the 
uterine cervix [24]. It is believed that through this process there is an accumulation of 
genetic and epigenetic alterations and more and more layers of the epithelium are 
progressively involved, until it is replaced by atypical cells in full length. It is considered 
that the more severe the degree of dysplasia, the greater the likelihood of malignant 
transformation. Despite the imperfection of currently available systems, they remain 
essential, and the diagnosis is a prerequisite for the establishment of the treatment that 
provides the best prognosis [12,24]. 
2.2. Proposed systems 
The elaboration of a classifying system is not a simple issue as the system may be, above all, 
an indicator of prognosis, guiding or at least helping in the establishment of the best 
treatment. Moreover, it should be reproducible, reliable, and as simple and objective as 
possible. Many classification schemes have been proposed over time, with variable 
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acceptance and employment. Herein, three of the most mentioned systems will first be 
discussed, followed by the recently suggested binary system. 
2.2.1. Squamous intraepithelial neoplasia (SIN) 
This classification is a modification of a previously suggested system for cervical pre-
malignant lesions, named cervical intraepithelial neoplasia [25]. After that, this concept has 
been adopted and extended to other sites, including oral mucosa, named “oral 
intraepithelial neoplasia” [12,26]. The term squamous intraepithelial neoplasia is also used 
to encompass all sites of the upper aerodigestive tract [26]. However, there is no evidence 
that many of the potentially malignant lesions of the oral mucosa are committed on a path to 
malignancy. Moreover, the SIN terminology would not clarify the knowledge concerning 
this issue, which would not justify replacing the widely accepted concept of dysplasia. 
Additionally, the WHO consensus group did not favour this system [12]. 
According to this system, lesions are classified as: 
 SIN 1, would be similar to mild dysplasia 
 SIN 2, would be similar to moderate dysplasia 
 SIN 3, would combine severe dysplasia and carcinoma in situ 
2.2.2. Ljubljana classification of squamous intraepithelial lesions 
This classification system was proposed by laryngeal pathologists in 1971 and additionally 
formulated in 1997 by a Working Group of the European Society of Pathology [27,28]. Very 
detailed criteria have been published and this system is more complex than the concept of 
dysplasia, so that even experienced pathologists would require time to adapt to it. 
Moreover, despite some publications, the usefulness of this grading system for oral lesions 
is doubtful [12,24]. 
Briefly, lesions are classified into four groups according to this system: 
 Simple hyperplasia, which is an increase in the stratum spinosum 
 Basal/parabasal cell hyperplasia or abnormal hyperplasia, considered essentially a basal 
cell hyperplasia 
 Atypical hyperplasia, also named risky hyperplasia, shows epithelial stratification, but  
with atypia 
 Carcinoma in situ, characterized by loss of stratification throughout epithelium, but 
three to five layers of compressed cells may be present on the surface. Also, there is 
marked atypia and mitotic abnormalities 
The first two degrees are considered mainly benign lesions, showing minimum risk for 
malignant transformation. The third degree would be a potentially malignant lesion, and the 
last one is actually considered a malignant lesion already. Additionally, the “atypical 
hyperplasia” and “carcinoma in situ” degrees are divided into basal cell type and spinous 
cell type [12,24]. 
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2.2.3. World health organization 
In 1997, the WHO published the “Histopathological Typing of Cancer and Precancer of the 
Oral Mucosa” and in the latest WHO’s classification of Head and Neck Tumours, a grading 
system based on “thirds” was described [7,29]. This resembled the system described since 
the 1970’s for lesions of the uterine cervix [24]. 
The WHO’s classification system is truly widely accepted among pathologists. However, it 
is not able to reflect the clinical behaviour of every single lesion and does not provide a clear 
therapeutic guideline to clinicians [24]. Moreover, in spite of its wide acceptance, this system 
presents great variability and low reproducibility [10,12]. According to it, lesions are 
allocated into categories considering firstly the architectural features, followed by 
cytological alterations [7].  
The architectural features that should be addressed are: 
 Irregular epithelial stratification (Figure 7) 
 Loss of polarity of basal cells (Figure 8) 
 Drop-shaped rete ridges 
 Increased number of mitotic figures 
 Abnormally superficial mitoses 
 Premature keratinisation in single cells (dyskeratosis) (Figure 9) 
 Keratin pearls within rete pegs 
 
 
        
 
Figure 7. Left: specimen of an oral leukoplakia showing irregular epithelial stratification. Right: Normal 
oral mucosa. Hematoxylin and eosin, 200X magnification.  
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Figure 8. Loss of polarity of basal cells in a photomicrograph of an oral leukoplakia specimen (arrows).  
Hematoxylin and eosin, 400X magnification. 
 
 
Figure 9. A keratinocyte showing dyskeratosis. Hematoxylin and eosin, 1000X magnification. 
The cytological alterations to be observed are as follows: 
 Nuclear pleomorphism: abnormal variation in nuclear shape (Figure 10) 
 Cellular pleomorphism: abnormal variation in cell shape (Figure 10) 
 Anisonucleosis: abnormal variation in nuclear size (Figure 10) 
 Anisocytosis: abnormal variation in cell size (Figure 10) 
 Increased nuclear size (Figure 10) 
 Increased nuclear-cytoplasm ratio (Figure 10) 
 Atypical mitotic figures (Figure 11) 
 Increased number and size of nucleoli (Figure 10 and 12) 
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Figure 10. Left: in this specimen, it can be noticed anisonucleosis, anisocytosis, nuclear and cellular 
pleomorphism, increased nuclear size, increased nuclear-cytoplasm ratio, and increased number and 
size of nucleoli of keratinocytes in an oral leukoplakia. Right: normal keratinocytes. Hematoxylin and 
eosin, 1000X magnification. 
 
Figure 11. Keratinocytes exhibiting atypical mitotic figures (arrows). Hematoxylin and eosin, 400X 
magnification. 
The observation of these alterations should be done considering the epithelium divided into 
“thirds”. Accordingly, lesions should be classified into five categories, as described below: 
1. Hyperplasia (Figure 13): describes a lesion showing an increase in cell number in the 
spinous layer and/or in the basal/parabasal cell layers. There is regular stratification and 
no cellular atypia. 
2. Mild dysplasia (Figure 14): architectural disturbance only in the lower third of the 
epithelium with cytological atypia. 
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3. Moderate dysplasia (Figure 15): architectural disturbance extending into the middle 
third of the epithelium is the initial criteria, but the degree of cytological atypia may 
require upgrading it to “severe”. 
4. Severe dysplasia (Figure 16): architectural disturbance affecting greater than two thirds 
of the epithelium, with cytological atypia. 
5. Carcinoma in situ (Figure 17): theorically, indicates that malignant transformation has 
occurred but invasion has not. Full or almost full thickness architectural disturbance in 
viable cellular layers with pronounced cellular atypia. Atypical mitotic figures and 
abnormal superficial mitoses are common. 
 
 
 
 
 
 
 
Figure 12. Oral leukoplakia specimen exhibiting increased number and size of nucleoli (arrows). 
AgNOR staining, 200X magnification. 
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Figure 13. Sample of an oral leukoplakia showing hyperplasia. Note an increased number of basal / 
parabasal cells and a hyperkeratotic surface. Regular stratification is observed, as well as no cytological 
atypia. Hematoxylin and eosin, 200X magnification. 
 
      
Figure 14. These specimens of oral leukoplakia exhibited mild dysplasia. Observe architectural 
disturbances affecting the lower third of the epithelium and cytological atypia. Hematoxylin and eosin, 
200X magnification (left), 400X magnification (right). 
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Figure 15. Microscopic presentation of an oral leukoplakia showing moderate dysplasia. Architectural 
disturbances extending into the middle third of epithelium, along with cytological atypia. Hematoxylin 
and eosin, 100X magnification. 
 
 
 
Figure 16. Histological section of oral leukoplakia exhibiting severe dysplasia. Architectural 
disturbances affecting greater than two thirds of the epithelium. Pronounced cytological atypia is 
evident. Hematoxylin and eosin, 100X magnification. 
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Figure 17. An oral leukoplakia that showed microscopic features of carcinoma in situ: architectural 
disturbances are observed in the full thickness of epithelium with pronounced cellular atypia. No 
superficial keratinisation can be observed. Hematoxylin and eosin, 200X magnification. 
2.2.4. Binary system 
As mentioned above, the proposed systems to grade epithelial dysplasia published so far, 
including the WHO’s proposal, showed some shortcomings, such as great variability and 
low reproducibility. Thus, studies concerning classification criteria are being performed, 
looking for an enhancement for grading epithelial dysplasia in OL. In 2006, a new binary 
system was proposed, which could be a more feasible and reliable tool for grading epithelial 
dysplasia in OL [15]. According to this system, pathologists would observe the same 
morphological criteria used in the WHO classification, but lesions would be classified as 
low-risk OL (former “no/ mild / questionable” dysplasia) or as high-risk OL (former 
“moderate/ severe” dysplasia) [15,10,12]. This would provide more reliable criteria upon 
which to rely for the selection of patient treatment. 
Interestingly, in 1988 the “Bethesda classification” for cervical cytopathology, already 
included only two grades [30]. According to this, lesions would be classified as low-grade 
squamous epithelial lesions, corresponding to former cervical intraepithelial neoplasia 
grade 1, and high-grade squamous epithelial lesions, corresponding to grades 2 and 3. This 
system has also been mentioned in some reports for oral lesions [26]. 
After the publication of those papers on the binary system for grading epithelial dysplasia in 
OL, a study was performed with 218 patients with OL, from which 39 (17.9%) developed 
into cancer [31]. The authors reported that high-risk OL was associated with a 4.57-fold 
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increased risk for malignant transformation, compared with low-risk OL. Those authors 
suggested that high-risk dysplasia would be a significant indicator for evaluating malignant 
transformation risk in OL.  
Subsequently, the same research group published a study in which they identified 
significant risk factors for malignant transformation in a long-term follow-up cohort of 
patients with oral epithelial dysplasia [32]. Of the 138 patients with histologically confirmed 
oral dysplasia, 115 had OL and 23 had lichen planus. From these 138 lesions, 37 (26.8%) 
developed into cancer and the “high-risk” degree of dysplasia was an independent risk 
factor for transformation. Moreover, high-risk degree of dysplasia was associated with a 
2.78-fold increased risk of transformation compared with low-risk degree. The authors then 
suggest the utilization of high-risk dysplasia as a significant indicator for evaluating 
malignant transformation risk in patients with potentially malignant lesions. According to 
them, this would also help guiding treatment in clinical practice. In spite of these great 
achievements, it must be mentioned that malignancy also developed in some patients 
previously presenting low-risk potentially malignant lesions [32]. 
In our first paper [33], we investigated the immunoexpression of hMLH1 (a protein of the 
mismatch repair system) (Figure 18) in OL with different degrees of dysplasia, according to 
the WHO grading system. We evaluated lesions showing no, mild, moderate, and severe 
dysplasia, and we found that the greater difference in the hMLH1 immunoexpression was 
detected comparing OL with mild and moderate dysplasia, with decreasing indexes. 
Therefore, we suggested that this result would be in accordance with the proposed binary 
system of grading dysplasia in OL, as the morphological dysplastic alterations observed in 
routinely stained slides may be related to molecular changes.  
    
Figure 18. Immunoexpression of hMLH1 in oral leukoplakia showing no dysplasia (left) and severe 
dysplasia (right). Advance HRP, 200X magnification. 
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After that, we conducted a comparative immunohistochemical and histochemical study 
encompassing those same samples of OL [34]. At that time, the hMLH1 immunoexpression 
was compared to p53 immunoexpression (Figure 19) and AgNOR counting. Thus, we could 
assess the possible association between a protein of DNA repair, a tumor suppressor 
protein, and the cellular proliferation in OL with different degrees of dysplasia, i.e. no, mild, 
moderate, and severe. We concluded that it seemed reasonable that other molecular 
alterations may take place in early phases of carcinogenesis, related to tumor suppressor 
genes, like p53, as well as modifications in proliferation rates. 
   
Figure 19. Immunoexpression of p53 in oral leukoplakia with mild dysplasia (left) and severe dysplasia 
(right). Streptoavidin-biotin, 100X magnification. 
Recently, we decided to reevaluate those previous results in the light of the binary system to 
grade epithelial dysplasia in OL [35]. Therefore, we grouped OL formerly classified as 
showing no and mild dysplasia into low-risk lesions. Accordingly, OL previously classified 
as having moderate and severe dysplasia were defined as high-risk lesions. After that, we 
performed the statistical analyses again. Our findings showed statistically significant 
differences for hMLH1, p53, and AgNOR indexes between low- and high-risk OL. This 
suggests that the biological processes linked to the impairment of those proteins remain 
enhancing from low-risk OL to high-risk OL. Thus, the use of the binary system would give 
support to a more reliable clinical approach involving the removal of high-risk OL. 
Moreover, we could speculate that OL classified as low-risk may be reasonably named this 
way, since comparisons between hMLH1 and AgNOR indexes of this group and normal 
oral mucosa did not reach statistical significance, despite their different median values.  
2.2.5. Other proposals 
Apart from those investigations pointing towards an adaptation of the WHO classification 
to a binary system, there are also other recently published papers on different proposals to 
evaluate epithelial dysplasia. 
As reviewed before, the Japanese Society for Oral Pathology reported a definition of 
carcinoma in situ and proposes the term “oral intraepithelial neoplasia”, which in turn could 
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be classified as differentiated and basaloid type [24]. The main difference between them 
would be the presence of keratinisation in the epithelium surface in the differentiated type. 
Additionally, some authors analyzed individual features of dysplasia in oral lesions and 
determined the reproducibility of scoring each one [36]. They suggested that those data 
might be used to improve or to develop simpler routine diagnostic methods. 
3. Conclusion 
To date, no system is free of presenting failures in identifying those OL prone to evolve to 
oral squamous cell carcinoma. Furthermore, the reproducibility and subjectivity are still key 
points to be addressed. Therefore, robust research on the predictive value, relevance, 
applicability, and feasibility of the binary system for grading epithelial dysplasia are clearly 
warranted. Such research should aim to establish of a reliable and reproducible method that, 
above all, could provide a better and less empiric clinical management of the patient. 
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